Advaxis Announces Agreement with Columbia University Irving Medical Center to Fund Phase 1 Study of ADXS-504 for the Treatment of Early Prostate Cancer Initiation of Phase 1 study in biochemically recurrent prostate cancer anticipated in Q2
April 05, 2021 08:00 ET | Source: Advaxis, Inc. Advaxis, Inc. Princeton, New Jersey, UNITED STATES
PRINCETON, N.J., April 05, 2021 (GLOBE NEWSWIRE) Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced an agreement with Columbia University Irving Medical Center to fund a Phase 1 clinical study evaluating ADXS-504 in patients with biochemically recurrent prostate cancer. The study, expected to begin in Q2 2021, will be the first clinical evaluation of ADXS-504, Advaxis’ off-the-shelf neoantigen immunotherapy drug candidate for early prostate cancer. Mark Stein, M.D., as
Advaxis (ADXS) Announces Agreement with Columbia University Irving Medical Center to Fund Phase 1 Study of ADXS-504 for the Treatment of Early Prostate Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
As telehealth visits become more common, here are ways you can make the most of your consultation
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Rare Immune Cell Type Explains How Body Keeps Common Virus in Check
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
School of General Studies student has died
School of General Studies student has died Courtesy Of / Bass-Cauthen Funeral Home & Cremation Center Matthew Avila, who was a first-year in the School of General Studies, passed away last month. By Dia Gill | April 1, 2021, 9:29 PM
Content warning: This article discusses the death of a student.
Matthew Avila, who was a first-year in the School of General Studies, passed away last month, Dean Lisa Rosen-Metsch wrote in an email to the General Studies community Thursday.
Before enrolling in General Studies, Avila graduated with honors with a degree in human development from Cornell University. Between graduating from Cornell in 2018 and beginning the Postbac Premed Program at the school of General Studies last fall, Avila was a research associate at Columbia Mailman School of Public Health as well as a clinical research coordinator at Columbia University Irving Medical Center. Avila, who Rosen-Metsch described as a “determined